These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15944517)

  • 21. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies of experimental calcium oxalate stones. 1. The calcium and magnesium of renal deposition of calcium oxalate induced by ethylene glycol administration].
    Ebisuno S; Morimoto S; Fukatani T; Miyazaki Y; Yasukawa S; Sawada Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):831-42. PubMed ID: 4068424
    [No Abstract]   [Full Text] [Related]  

  • 23. Vitamin D and calcium kidney stones: a review and a proposal.
    Tavasoli S; Taheri M
    Int Urol Nephrol; 2019 Jan; 51(1):101-111. PubMed ID: 30136085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
    Gambaro G; Baggio B
    Scanning Microsc; 1992 Mar; 6(1):247-54. PubMed ID: 1626244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of sex hormones in experimental calcium oxalate nephrolithiasis.
    Fan J; Chandhoke PS; Grampsas SA
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S376-80. PubMed ID: 10541267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3].
    Okada Y; Kawamura J; Nonomura M; Kuo YJ; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic calcium phosphate nephrolithiasis.
    Gault MH; Parfrey PS; Robertson WG
    Nephron; 1988; 48(4):265-73. PubMed ID: 3283583
    [No Abstract]   [Full Text] [Related]  

  • 28. Nephrolithiasis: diagnosis and medical management.
    Wilson DR
    Compr Ther; 1981 Nov; 7(11):31-9. PubMed ID: 7318396
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL; Parks JH
    Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958
    [No Abstract]   [Full Text] [Related]  

  • 31. Insights into the pathophysiology and treatment of patients with calcium oxalate nephrolithiasis.
    Assimos DG
    J Urol; 1998 May; 159(5):1457-8. PubMed ID: 9554332
    [No Abstract]   [Full Text] [Related]  

  • 32. The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits.
    Barr-Beare E; Saxena V; Hilt EE; Thomas-White K; Schober M; Li B; Becknell B; Hains DS; Wolfe AJ; Schwaderer AL
    PLoS One; 2015; 10(10):e0139575. PubMed ID: 26448465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis].
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephrologie; 1984; 5(4):173-4. PubMed ID: 6527719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National multi-institutional cooperative on urolithiasis in children: Age is a significant predictor of urine abnormalities.
    Cambareri GM; Kovacevic L; Bayne AP; Giel D; Corbett S; Schurtz E; Sukhu T; Chiang G
    J Pediatr Urol; 2015 Aug; 11(4):218-23. PubMed ID: 26119451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of calcium oxalate kidney stones with thiazides].
    Alon U; Better OS
    Harefuah; 1982 Apr; 102(8):338-40. PubMed ID: 7117975
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nephrolithiasis--the mechanism and progression of nephrolithiasis].
    Yasui T; Okada A; Itoh Y; Tozawa K; Kohri K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():618-22. PubMed ID: 16523965
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation.
    Yagisawa T; Chandhoke PS; Fan J
    Urology; 1998 Nov; 52(5):750-5. PubMed ID: 9801093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxalate: from the environment to kidney stones.
    Brzica H; Breljak D; Burckhardt BC; Burckhardt G; Sabolić I
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):609-30. PubMed ID: 24384768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.